Bristol-Myers Squibb Company · NYSE:BMY
Bristol-Myers Squibb — Patient Advocate Foundation — Bristol-Myers Squibb Foundation Grantee Summit 2016
13 slides from Bristol-Myers Squibb's conference presentation, 2016
Slide 1: Bristol-Myers Squibb Foundation Grantee Summit 2016
Bristol-Myers Squibb Foundation Grantee Summit 2016 yers Squibb Foundation ialty Care for ble Populations Bridging Cancer Care” Care Collaborations & Patient Support Caine, seer
Slide 2: Linking Low Income West Virginia Lung Cancer Patients to Case Management Support
Linking Low Income West Virginia Lung Cancer Patients to Case Management Support Shonta Chambers EVP Health Equity Initiatives and Programs Patient Advocate Foundation
Slide 3: Who is PAF?
Who is PAF? PAF employs professional case managers with experience in coding and billing, public health and disability systems, insurance, nursing and much more. Highly-rated national 501 c(3) charity nonprofit earing 6 consecutive 4-star Charity Navigator designations and numerous Case Management a
Slide 4: Our Mission Our Impact
Our Mission Patient Advocate Foundation seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases. Our Impact Since our inception in
Slide 5: What Does PAF Do?
What Does PAF Do? Patient Advocate Foundation seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability. • Provide real-time help for TODAY’s • Free assistance to patients, caregivers, needs. or their POC
Slide 6: The Need
The Need • WV ranks among the top states in public risk factors for tobacco use1 and among the bottom in American’s Health ranking. • Age-adjusted WV lung cancer rates for men and women are statistically significantly greater than the corresponding US rates; approximately one-fifth of lung cancers a
Slide 7: The Intervention
The Intervention • To navigate Medicaid Managed Care Beneficiaries to lung cancer screenings, and where appropriate, lung cancer diagnosis. • To establish a case management platform designed to support providers and patients with lung cancer. • Link Medicaid Managed Care Beneficiaries with a confirm
Slide 8: Project Goals
Project Goals • Increased lung cancer screening among eligible Medicaid Managed Care beneficiaries • Improved early diagnosis of lung cancer among low-income and limited resources individuals • Increased access and adherence to lung cancer treatment • Decreased lung cancer mortality
Slide 9: Key Partners
Key Partners • American Cancer Society • Coventry Cares of West Virginia • WVU Cancer Institute • WV Hospital Association/WV Tobacco Coalition • West Virginia Prevention Research Center • Mountains of Hope Cancer Coalition
Slide 10: PAF WV LC Project Stakeholder Matrix
Coventry Cares of West Virginia WVU Cancer Ins0tute PAF WV LC WV Hospital Associa0on/WV Tobacco Coali0on Pa0ent Advocate Founda0on Project West Virginia Preven0on Research Center Stakeholder Engagement Provider Outreach/ Matrix Engagement Medicaid Managed Care Mountains of Hope West Virginia Pa0ent/
Slide 11: Key Activities
Key Activities Provider Outreach/Engagement • Assessment of providers knowledge, attitudes, behaviors and beliefs regarding lung cancer screening • Identify provider needs in regards to address non-clinical barriers to care • Implement systemic practice improvements to support ongoing lung cancer sc
Slide 12: Key Activities
Key Activities Case Management • Establish Lung Cancer CareLine • Develop implement referral protocol for Medicaid Managed Care Providers • Develop and implement referral protocol for ACS project FQHC • Enroll uninsured Medicaid eligible individuals into West Virginia Medicaid Program Evaluation • D
Slide 13: The work goes on, the cause endures
“The work goes on, the cause endures, the hope still lives and the dreams shall never die.” The late Senator Edward M. Kennedy Thank you for your interest in being part of the cause and for supporting the provision of hope for patients in nationwide. Our work is not done. We look forward to building
Patient Advocate Foundation — Bristol-Myers Squibb Foundation Grantee Summit 2016 on 6ix